Avelos Therapeutics
PrivateLast Round
Series B
Apr 30, 2024
Total Funding Raised
$29.97M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Avelos Therapeutics is a biotechnology company that specializes in the research and development of biomarker-driven, small molecule targeted therapies for cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Avelos Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Avelos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 30, 2024 | ||||
| Series A | Aug 22, 2022 | ||||
| Series A | Jul 1, 2022 | ||||
| Seed | Feb 1, 2022 |
Key People
Founding team and executive leadership
Avelos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series A, Series B |
| UTC Investment | Series A |
| Infobank Corp | Seed |
| QUAD Investment Management | Series A, Series B |
| STASSETS INVESTMENT | Series B |
| Timefolio Asset Management | Series A, Series B |
| Heungkuk Securities | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 77% MoM.
- Mar 2, 2026
Monthly visitors increased 114% MoM, reaching 2.7K.
Avelos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Avelos Therapeutics's valuation, stock price, and market status.